CRISPR Therapeutics AG

Filed a patent for "modulating expression of alas1 (5'-aminolevulinate synthase 1) gene" on Fri, July 21, 2023

Filed a patent for "modulating expression of alas1 (5'-aminolevulinate synthase 1) gene" on Mon, November 13, 2023

Filed a patent for "modulating expression of alas1 (5'-aminolevulinate synthase 1) gene" on Wed, January 24, 2024

Filed a patent for "masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (ptk7) and immune cells expressing such" on Thu, October 24, 2024

Filed a patent for "compositions and methods for the depletion of cd117+ cells" on Thu, October 31, 2024

Filed a patent for "compositions and methods for gene editing" on Thu, September 26, 2024

Filed a patent for "materials and methods for treatment of glycogen storage disease type 1a" on Thu, July 11, 2024

Filed a patent for "methods and compositions for treating angiopoietin-like 3 related conditions" on Thu, June 16, 2022

Filed a patent for "materials and methods for treatment of myotonic dystrophy type 1 (dm) and other related disorders" on Thu, July 20, 2023

Filed a patent for "universal donor cells" on Thu, March 9, 2023

Filed a patent for "anti-idiotype antibodies targeting anti-cd19 chimeric antigen receptor" on Thu, April 6, 2023

Filed a patent for "gene-edited natural killer cells" on Thu, April 27, 2023

Filed a patent for "genetically engineered immune cells having a disrupted cd83 gene" on Thu, April 27, 2023

Filed a patent for "t-cell bispecific binding proteins" on Thu, June 15, 2023

Filed a patent for "universal donor cells" on Thu, April 27, 2023

Filed a patent for "high purity grna synthesis process" on Thu, July 13, 2023

Filed a patent for "prodrug incorporated sgrna synthesis" on Thu, April 6, 2023

Filed a patent for "materials and methods for treatment of pain related disorders" on Thu, September 7, 2023

Filed a patent for "genetically engineered anti-cd19 car-t cells for use in treating b-cell malignancies" on Mon, October 10, 2022

Filed a patent for "myoc knockdown for glaucoma treatment" on Tue, October 18, 2022

Filed a patent for "anti-cd83 car-t cells with regnase-1 and/or tgfbrii disruption" on Thu, October 20, 2022

Filed a patent for "methods and compositions for treating angiopoietin-like 3 related conditions" on Fri, October 21, 2022

Filed a patent for "mask peptides and masked anti-ptk7 antibodies comprising such" on Thu, June 15, 2023

Filed a patent for "genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistence" on Thu, August 24, 2023

Filed a patent for "gene editing for hemophilia a with improved factor viii expression" on Thu, September 14, 2023